Related by context. All words. (Click for frequent words.) 75 dasatinib Sprycel 72 dasatinib Sprycel ® 71 vinca alkaloid 71 docetaxel Taxotere ® 71 erlotinib Tarceva ® 71 cetuximab Erbitux R 71 Mg Usa 70 metaglidasen 70 nilotinib Tasigna 70 vapreotide acetate 70 PNP inhibitor 70 proteasome inhibitor 70 hormone LHRH antagonist 70 CYT# potent vascular disrupting 70 AAG geldanamycin analog 70 nilotinib Tasigna ® 70 AKT inhibitor 69 hypereosinophilic syndrome 69 refractory chronic lymphocytic 69 imatinib Gleevec ® 69 HGS ETR1 mapatumumab 69 either acutely decompensated 69 developing Bicifadine serotonin 69 imatinib Gleevec 69 receptor tyrosine kinase inhibitor 69 bevacizumab Avastin ® 69 targeted antifolate 69 liposomal formulation 69 erlotinib Tarceva R 69 Atripla combines 69 HCV NS5B polymerase 68 generation purine nucleoside 68 SPRYCEL ® 68 kidney urologic 68 accumulate preferentially 68 evaluating picoplatin 68 ® lenalidomide 68 EGFR TKIs 68 R sorafenib tablets 68 evaluating tivozanib 68 acetonide FA 68 XL# XL# 68 IMiDs ® 68 itraconazole Sporanox 68 Omacetaxine 68 targeted radiotherapeutic 68 docetaxel Taxotere R 68 nucleoside analog 68 multi kinase inhibitor 68 immunomodulating 68 ENMD # 68 Peginterferon alfa 2b 68 oral prodrug 68 IMiDs R 68 biologic DMARD 67 echinocandin 67 brand ciclesonide HFA 67 non peptidic protease 67 Mg Uk 67 HSP# inhibitor 67 sorafenib Nexavar 67 xanthine oxidase inhibitor 67 Hsp# Inhibitor 67 thalidomide Thalomid 67 5 FU leucovorin 67 Fludarabine 67 IAP inhibitor 67 Gleevec resistant 67 Annamycin 67 metastatic CRC 67 orally bioavailable 67 direct thrombin inhibitors 67 vinorelbine tartrate 67 pan HDAC inhibitor 67 bevacizumab Avastin R 67 non nucleoside inhibitor 67 histone deacetylase inhibitor 67 mertansine 67 myelodysplastic myeloproliferative diseases 67 humanised monoclonal antibody 67 5 HT3 antagonist 67 Aflibercept 67 PEGylated Fab fragment 67 chronic eosinophilic leukemia 67 candidates Azedra TM 67 Investigational Oral 67 R lenalidomide 67 topical antifungal 67 ALK inhibitor 67 Ozarelix 67 relapsed MM 67 ADP receptor antagonist 67 PRN FDA Approves 67 anti secretory 67 FUSILEV enhances 67 pharmacologically active isomer 67 Tarceva TM 67 PKC# 67 PI3K/Akt pathway inhibitor 67 small molecule tyrosine 67 anionic backbone 67 pan histone deacetylase 67 indinavir Crixivan 67 PDE4 inhibitor 66 Sapacitabine 66 Zorbtive TM 66 fusion enhancers 66 tyrosine kinase inhibitor 66 VitiGam 66 antimitotic 66 Orally administered 66 Gleevec imatinib mesylate 66 Kinase Inhibitor 66 Meets Primary Endpoint 66 histone deacetylase HDAC inhibitor 66 cetuximab Erbitux ® 66 5 fluorouracil leucovorin 66 Naive Patients 66 dexamethasone Decadron 66 non porcine pancreatic 66 Pazopanib 66 CYP#A# substrate 66 Fludara ® 66 beta 1a 66 Lenalidomide 66 Dasatinib 66 FOLFOX6 chemotherapy regimen 66 gefitinib Iressa 66 pegylated interferons 66 humanized therapeutic 66 Plaque Psoriasis 66 protein tyrosine phosphatase 1B 66 Elotuzumab 66 orally administered inhibitor 66 alkylating agent 66 ALN HPN 66 telaprevir dosed 66 Selzentry Celsentri 66 IMiDs ® compound 66 ceftazidime 66 novel VDA molecule 66 somatostatin analogue 66 selective kinase inhibitor 66 tyrosine kinase inhibitors TKIs 66 AZT zidovudine Retrovir 66 EGFR TKI 66 alpha folate receptor 66 lumiliximab 66 Ganciclovir 66 receptor modulators 66 LymphoStat B TM 66 TAFA# 66 alefacept 66 novel histone deacetylase 66 sorafenib tablets 66 immunotherapeutic agent 66 VEGF inhibitors 66 BCG refractory carcinoma 66 Litx 66 Methylnaltrexone 66 JAK2 Inhibitor 66 Exelixis compounds 66 NS5b 66 Kinoid 66 includes AstraZeneca Accolate 66 relapsed CLL 66 panitumumab Vectibix R 66 LymphoStat B belimumab 66 NS5B polymerase 66 small molecule thrombopoietin 66 antifibrotic 66 Ecallantide 66 oral vancomycin 66 vincristine doxorubicin 66 investigational humanized monoclonal antibody 66 miconazole Lauriad ® 66 cutaneous T 66 5 Fluorouracil 66 imatinib mesylate 66 novel emulsion formulation 66 Blinatumomab 66 GRNOPC1 contains 66 rxRNA 66 acyclovir Lauriad R 66 pegylated interferon alpha 66 triciribine phosphate monohydrate 66 investigational monoclonal antibody 66 Angiotensin Converting Enzyme 65 microtubule inhibitor 65 IMiDs 65 humanized anti 65 Daclizumab 65 CYP#A# CYP#D# 65 Aeolus Pharmaceuticals Announces 65 PRT# 65 refractory chronic myeloid 65 JAK inhibitors 65 imatinib therapy 65 Actemra tocilizumab 65 CCR9 antagonist 65 CD4 monoclonal antibody 65 myelofibrosis polycythemia vera 65 Anthracycline 65 ara C 65 Aurora Kinase 65 CCX# 65 nucleoside reverse transcriptase inhibitor 65 LHRH antagonists 65 Combivir Kivexa 65 Romidepsin 65 idarubicin 65 voriconazole 65 metastatic renal cell carcinoma 65 TOCOSOL Camptothecin 65 prostanoid 65 Cobalamin TM mediated 65 ChronVac C R 65 multiple myeloma MM 65 TNF alpha antagonist 65 Sanvar R 65 HuMax 65 cyclophosphamide chemotherapy 65 ® bortezomib 65 signal transduction inhibitor 65 Gamunex C 65 XP# XP# 65 lenalidomide Revlimid R 65 plus dacarbazine 65 peripherally acting 65 NNRTIs 65 XL# anticancer compounds 65 Bayer HealthCare Onyx Pharmaceuticals 65 TRIOLEX ™ 65 virus HCV protease inhibitor 65 tenofovir disoproxil fumarate Viread 65 nilotinib 65 adalimumab Humira 65 investigational therapies 65 MTP inhibitor 65 Pertuzumab 65 Preclinical studies suggest 65 metastatic malignant 65 Personalized Immunotherapy 65 immune modulating 65 Bcr Abl T#I mutation 65 BCR ABL inhibitor 65 antiangiogenesis therapies 65 plus prednisone prednisolone 65 anthracycline containing 65 tigecycline 65 Albuferon TM 65 prokinetic agent 65 alkylating 65 Irinotecan 65 non nucleoside 65 sodium glucose cotransporter 65 Kuvan sapropterin dihydrochloride 65 leukemia AML 65 intranasal formulation 65 mTOR inhibitor 65 Janus Kinase 65 oral proteasome inhibitor 65 Vidaza ® 65 chemically modified siRNA 65 liposome encapsulated 65 Pemetrexed 65 somatostatin analog 65 IAP inhibitors 65 ganciclovir 65 Anidulafungin 65 vinca alkaloids 65 MEK Inhibitor 65 targeting CD# 65 Dementia Related Psychosis 65 paclitaxel Taxol ® 65 investigational oral inhibitor 65 systemic antifungal 65 Voreloxin 65 DU #b 65 Elagolix 65 oral picoplatin 65 HCV RNA polymerase 65 INSPIRE Trial Phase III 65 Medoxomil 65 5 HT2A inverse 65 HCV NS3 protease 65 oropharyngeal candidiasis OPC 65 Mipomersen 65 sunitinib Sutent ® 65 R Saizen R 65 oral dihydropyrimidine dehydrogenase DPD 65 Alfacell proprietary ribonuclease 65 CCR5 receptor antagonist 65 Kit CD# positive 65 anti angiogenic agent 65 alfa 2a 65 irinotecan hydrochloride 65 sapacitabine CYC# 65 ritonavir boosted 65 cell lymphoma CTCL 65 mTOR mammalian target 65 relapsed multiple myeloma 65 gastrointestinal stromal tumors GIST 65 PEGylated anti 65 long acting bronchodilator 65 essential thrombocythemia ET 65 TLR9 agonist 65 antiangiogenic agent 65 TELINTRA 65 delivery polymer matrix 65 Forodesine 65 ergot derivatives 65 pegylated alpha interferon 65 advanced metastatic renal 64 IgG1 monoclonal antibody 64 Genentech Rituxan 64 OMP #R# 64 Dabigatran etexilate 64 xenograft models 64 biologic therapy 64 Anti VEGF 64 Herceptin trastuzumab 64 Pegloticase 64 peripherally restricted 64 Lubiprostone 64 peptibody 64 Triapine 64 MAGE A3 ASCI 64 delivers fluocinolone acetonide FA 64 BCR ABL inhibitors 64 ATRA IV 64 demethylating agent 64 fluoropyrimidine 64 Temsirolimus 64 receiving immunosuppressive therapy 64 Nexavar sorafenib 64 chemotherapy FOLFOX 64 FVIIa 64 HepDirect prodrug 64 irinotecan containing 64 GW# [003] 64 SinuNase TM 64 Rigel R# 64 Talabostat 64 dornase alfa 64 luteinizing hormone releasing 64 XmAb ® 64 serologically active systemic lupus 64 proprietary PEGylation 64 histone deacetylase HDAC 64 TKIs 64 Xeloda capecitabine 64 Liprotamase 64 HGS# 64 CCR5 antagonist 64 HMG CoA reductase inhibitors 64 galiximab 64 small molecule Hedgehog 64 Acute Myeloid Leukemia AML 64 Completes Patient Enrollment 64 Initiates Clinical Trial 64 nucleotide analog 64 cyclophosphamide methotrexate 64 coronary stent merged 64 refractory NSCLC 64 Recombinant interferon alpha 64 recurrent NSCLC 64 memantine HCl 64 gemcitabine Gemzar 64 Tyrima 64 K ras mutations 64 Fc fusion protein 64 Pharmacokinetics PK 64 Epidermal Growth Factor Receptor 64 Tesmilifene 64 XL# XL# XL# XL# 64 Provectus Pharmaceuticals specializes 64 ABL inhibitor 64 anthracycline taxane 64 tenofovir emtricitabine 64 Hycamtin ® 64 Simulect 64 Romiplostim 64 Vidofludimus 64 Navelbine ® 64 calcineurin inhibitor 64 imatinib resistant 64 Vicriviroc 64 2 methoxyestradiol 64 verteporfin 64 chimeric monoclonal antibody 64 lipoglycopeptide 64 HuLuc# 64 TKI therapy 64 Crofelemer budesonide foam 64 Vinorelbine 64 bortezomib Velcade 64 VEGFR2 inhibitor 64 selective orally bioavailable 64 TNF Tumor Necrosis Factor 64 CHOP chemotherapy 64 Enhanze Technology 64 oral antiviral 64 Pegasys peginterferon alfa 2a 64 Azacitidine 64 Epothilones 64 novel peptide 64 herpetic keratitis 64 CML CP 64 Nilotinib 64 oral Hsp# inhibitor 64 inflammatory PDE 64 albumin bound paclitaxel 64 familial amyloidotic polyneuropathy FAP 64 selective antagonist 64 Plicera 64 Cutaneous T 64 M2 subunit 64 MGd 64 Tipranavir 64 Elvitegravir 64 SUTENT ® 64 subcutaneously administered 64 including cyclosporine methotrexate 64 metastatic colorectal 64 Patients Treated With 64 Relapsed Refractory 64 basiliximab 64 regorafenib 64 Deforolimus 64 PORxin TM 64 beta lactamase inhibitor 64 Pruvel TM 64 interferon alpha IFN 64 interferon alpha IFN alpha 64 leukotriene receptor antagonist 64 Factor Receptor 64 PEGylated interferon 64 highly selective endothelin 64 INTEGRILIN R 64 macrolide antibiotic 64 peptidic compound 64 systemic fungal infections 64 VALSTAR 64 Tumor Necrosis Factor 64 potently inhibit 64 Vidaza azacitidine 64 attach auristatin 64 CTAP# Capsules 64 HDAC Inhibitor 64 antiplatelet medications 64 assessing T DM1 64 YONDELIS 64 Treatment Naïve 64 etanercept Enbrel 64 Amrubicin 64 castrate resistant prostate cancer 64 small molecule glucokinase 64 5 HT2A serotonin 64 BHT DNA 64 Iluvien ® 64 mTOR inhibitors 64 SPRIX ® 64 lintuzumab SGN 64 SinuNase ™ 64 HCV polymerase 64 Myelodysplastic Syndrome MDS 64 diagnostic molecular imaging 64 reverse transcriptase inhibitors 64 recurrent metastatic ovarian cancer 64 Panzem R 64 cidofovir 64 A1PI 64 maximally tolerated dose 64 Novel Oral 64 metastatic hormone refractory 64 Myocet 64 DMARDS 64 Eraxis 64 AEG# 64 Pafuramidine 64 Aliskiren 64 mRCC 64 IL# PE#QQR 64 systemic RNAi therapeutic 64 Curaxin CBLC# 64 estrogen receptor antagonist 64 Sudhir Agrawal D.Phil 64 Ribavirin causes 64 pathophysiological effects 64 Pegasys ® 64 Tasimelteon 64 HQK 64 Fluconazole 64 effector function 64 Traficet EN 64 OMNARIS HFA 64 trastuzumab Herceptin R 64 rHuPH# recombinant human 64 forodesine 64 Ovitrelle R Serostim 64 radezolid 64 sulfonylhydrazine class 64 highly selective inhibitor 64 CFTR corrector 64 DEB# 64 selective modulator 64 Tyrosine Kinase Inhibitor 63 Bosutinib 63 Complicated Skin 63 antimetabolite 63 atypical hemolytic uremic syndrome 63 Amgen Neulasta R 63 including eniluracil ADH 63 Pegylated Interferon 63 Lixivaptan 63 dacarbazine 63 Piperacillin 63 melphalan prednisone 63 MT#/MEDI-# 63 calcineurin inhibitors 63 TBC# 63 tumor vascular disrupting 63 topical ophthalmic 63 triggers apoptosis programmed 63 Epratuzumab 63 biologic antibody 63 panitumumab Vectibix 63 estramustine 63 humanized monoclonal antibodies 63 monoclonal antibody IgG1 Mab 63 Intravitreal injections 63 Liposomal 63 cisplatin gemcitabine 63 KSP inhibitor 63 tyrosine kinase inhibitors 63 sunitinib Sutent 63 MKC# MT 63 Vfend 63 reslizumab 63 BAL# [002] 63 Vitrasert R 63 colorectal cancer liver metastases 63 IL-#/# 63 Initiates Phase II 63 trabectedin 63 proteasome inhibitors 63 Atypical Hemolytic Uremic Syndrome 63 molecularly targeted 63 poly ADP ribose polymerase 63 endocrine therapies 63 Drug Candidate 63 refractory metastatic 63 novel topoisomerase 63 ALN PCS 63 Hedgehog Pathway Inhibitor 63 T#I [002] 63 NanoEmulsion 63 M# rationally 63 bendamustine 63 Taxol ® 63 thromboxane A2 63 CD# monoclonal antibody 63 bexarotene 63 Janus kinase 63 Photodynamic therapy PDT 63 Glufosfamide 63 Hormone Refractory Prostate Cancer 63 tubulin inhibitor 63 metastatic GIST 63 RLY# 63 alvespimycin 63 immunoconjugate 63 topical gel formulation 63 biliary tract cancer 63 oral antifungal 63 Vidaza R 63 Dapagliflozin 63 bortezomib Velcade R 63 TLK# 63 Opterone R 63 CDP# 63 tazobactam 63 Camptosar ® 63 metastatic neuroendocrine tumors 63 PSMA ADC 63 CLL SLL 63 Prolongs Survival 63 anti amnesic 63 opioid receptor antagonist 63 protease inhibitor PI 63 posaconazole 63 pegfilgrastim 63 disease modifying antirheumatic 63 Platinol ® cisplatin 63 EZN 63 MET amplification 63 BUPHENYL R 63 Squalamine 63 nucleoside analogues 63 Selective Inhibitor 63 dopamine partial agonist 63 HER2 overexpression 63 Achieves Primary Endpoint 63 miconazole Lauriad R 63 intravesical instillation 63 Panzem R NCD 63 Pfizer Camptosar 63 DURECT proprietary 63 standard chemotherapy regimens 63 Initiate Clinical Trial 63 investigational immunotherapy 63 Seliciclib 63 amikacin 63 Peginterferon 63 Diabetic Foot Ulcer 63 Firdapse TM amifampridine phosphate 63 oral transmucosal 63 Evoltra ® 63 immune modulatory 63 Immunotherapeutic 63 tetracycline antibiotic 63 caspofungin 63 immunomodulatory therapy 63 Quinamed 63 Epirubicin 63 pancreatic enzyme replacement 63 Sustiva efavirenz 63 ZOLINZA 63 huN# DM1 63 DiLA2 63 tipifarnib 63 MT# MEDI 63 EGFR HER2 63 evaluating satraplatin 63 Phase 2b Clinical Trial 63 CIMZIA TM certolizumab pegol 63 toenail onychomycosis 63 Locked Nucleic Acid 63 d l leucovorin 63 potently inhibited 63 Dyax phage display 63 selective inhibition 63 drug DMARD 63 azacytidine 63 riboflavin vitamin B2 63 vorinostat 63 fumarate 63 Saizen R 63 CYT# QbG# 63 Presents Preclinical 63 DIFICID ™ 63 Cytarabine 63 Interferon alfa 63 BiTE ® 63 reversible inhibitors 63 azoles 63 GVAX ® 63 Cethromycin 63 TKB# 63 nicardipine 63 IRX 2 63 PegIFN RBV 63 mda 7 63 intravesical infusion therapy 63 benzimidazole 63 JAK1 63 Polymerase Inhibitor 63 intravesical 63 DsiRNA 63 thymidylate synthase TS 63 develop HBV reactivation 63 potent topoisomerase II 63 iobenguane 63 patients coinfected 63 substrates inhibitors 63 topically administered 63 vidofludimus 63 polymerase inhibitor 63 busulfan 63 Soliris eculizumab 63 FOLFOX chemotherapy 63 OMP #M# 63 proprietary polysaccharide 63 immunomodulator 63 targeting miR 63 MKC# MKC# PP 63 methylnaltrexone bromide 63 potentially hepatotoxic 63 gemcitabine Gemzar ® 63 infliximab monotherapy 63 novel immunomodulatory 63 mapatumumab 63 dihydrofolate reductase 63 cyclin dependent kinase CDK 63 Boceprevir 63 Cloretazine 63 cytidine nucleoside analog 63 TO AVOID PREGNANCY WHILE 63 esophageal candidiasis 63 Denufosol 63 OHR/AVR# 63 IOP lowering 63 Neulasta R 63 mycophenolate mofetil 63 SCH # 63 meropenem 63 multitargeted 63 paclitaxel Taxol 63 hepatoprotective agent 63 platform HDL Mimetic 63 investigational pharmacologically unique 63 Anticalins R 63 elotuzumab 63 interferon ribavirin 63 IMA# 63 CIMZIA ™ 63 AEGR 63 Smac mimetics 63 Cytotoxic 63 pigmentary disorders 63 prescribed proton pump 63 anthracyclines taxanes 63 D aspartate NMDA receptor 63 ALN TTR 63 HCD# [002] 63 interferon gamma 1b 63 pegylated interferon peg IFN 63 Pyridorin 63 Gleevec Glivec 63 haematological malignancies 63 Initiates Clinical 63 AERx ® 63 octreotide acetate 63 Nexavar ® 63 Aviptadil 63 CBLC# 63 Tumour Vascular Disrupting Agent 63 maturation inhibitors 63 Xcytrin R 63 4 PDE4 enzyme 63 Aurora kinase inhibitor 63 papillary renal cell carcinoma 63 CYC# 63 anti angiogenic agents 63 anti mitotic 63 CD# CEA 63 hyaluronidase enzyme 63 thetreatment 63 Serostim ® 63 Doxorubicin 63 vascular disrupting agents 63 pegylated interferon alfa 2a 63 leukemia CLL 63 platinum chemotherapeutic 63 peptidomimetic 63 Receives Orphan Drug Designation 63 TNF antagonist 63 KL4 Surfactant 63 ribavirin RBV 63 cytotoxic therapy 63 P#X# antagonist 63 pyrazinamide 63 TELINTRA R 63 TRIOLEX HE# APOPTONE HE# 63 neuronal nicotinic receptor NNR 63 PDX pralatrexate 63 systemic immunosuppressive drugs 63 ALVESCO ® 63 MYDICAR ® 63 Gefitinib 63 infectious diseases autoimmune diseases 63 selectively inhibited 63 Protein Kinase C 63 unfractionated heparin UFH 63 Neulasta ® 63 denileukin diftitox 63 EGFR inhibitors 63 Maribavir 63 RezularTM 63 antibody MAb 63 Fludara 63 agents Tabun Sarin 63 oral ghrelin agonist 63 oral ferric iron 63 LHRH 63 Advanced Renal Cell 63 renin inhibitors 63 acute GvHD 63 Zoraxel TM 63 Capecitabine 63 therapeutic monoclonal antibody 63 PROCRIT ® 63 gamma secretase inhibitor 63 Initiates Enrollment 63 atypical Hemolytic Uremic Syndrome 63 Intravitreal 63 SERCA2a 63 chronic idiopathic thrombocytopenic purpura 63 AMEVIVE 63 Treatment Experienced 63 Pathway Inhibitor 63 Clindamycin 63 selective agonist 63 Microwave Ablation System 63 constipation OIC 63 humanized antibody 63 DG# compounds targeting 63 aripiprazole Abilify 63 Locked Nucleic Acid LNA 63 immunotoxin 63 adenosine injection 62 Tiuxetan 62 Pralatrexate 62 BrachySil TM 62 liposomal doxorubicin 62 goserelin 62 volociximab 62 oral transdermal 62 Imatinib mesylate 62 orally administered synthetic retinoid 62 Xanafide 62 folate analogue metabolic 62 protein kinase inhibitors 62 Foradil Aerolizer 62 chemotherapy induced neutropenia 62 treat atopic dermatitis 62 Syndrome LEMS 62 diarrhea predominant irritable 62 Pimavanserin 62 Noxafil 62 Aganocide 62 COPEGUS R 62 RNAi Therapeutic 62 Dalbavancin 62 aplastic anemia AA 62 Vandetanib 62 pegylated liposomal doxorubicin 62 human IgG1 monoclonal 62 potent antiproliferative 62 administered concomitantly 62 Lamictal ODT 62 DNA methyltransferase inhibitors 62 MEK inhibitors 62 PegIFN 62 ritonavir boosted protease inhibitor 62 novel antiviral therapeutics 62 irinotecan doxorubicin oxaliplatin paclitaxel 62 Oral NKTR 62 lamivudine 3TC 62 NAGS deficiency 62 Oracea TM 62 trimethoprim sulfamethoxazole 62 ® imatinib mesylate 62 Nucleoside 62 taxane chemotherapy 62 metastatic colorectal carcinoma 62 Aplidin 62 maximally tolerated lipid lowering 62 nucleoside naive 62 Tofacitinib 62 Xeloda ® 62 TRACON Pharmaceuticals 62 BiTE 62 CDK inhibitor 62 Golimumab 62 CD# expressing 62 Sutent sunitinib 62 Anti Bacterial Envelope 62 Kahalalide F 62 antiandrogen 62 nitric oxide donating 62 NXL# 62 erlotinib Tarceva 62 gastrointestinal disorders ATI 62 Pancreate 62 TNF alpha inhibitor 62 gemcitabine carboplatin 62 corticosteroid dexamethasone 62 combinability 62 reversible inhibitor 62 recurrent glioblastoma multiforme 62 LHRH receptor positive 62 Doxil ® 62 Nanobody 62 AMPK activators 62 MYLOTARG 62 oral anti arrhythmic 62 Inhalation Aerosol 62 oral kinase inhibitor 62 cromolyn sodium 62 HepaMate 62 PrevOnco 62 inhibitor PPI 62 CEQ# 62 patented Bioral 62 modified glutathione analog 62 SAR# [004] 62 selective adhesion molecule 62 RONDEL TM 62 progressive metastatic prostate 62 Lenocta TM sodium stibogluconate 62 HDACi 62 lapatinib Tykerb 62 Erlotinib 62 Bevacizumab 62 Bezielle 62 Begins Dosing 62 PDE# 62 decompensated liver disease 62 evaluating T DM1 62 fusion inhibitor 62 factor G CSF 62 Darinaparsin 62 topically applied SEPA 62 oncolytic virus therapies 62 drug zotarolimus 62 anti TNF alpha 62 MCSP respectively 62 demonstrated anti amnesic 62 chemotherapeutic drug 62 OncoVEX GM CSF 62 oral rivaroxaban 62 GTC recombinant human 62 NEUGENE 62 immunologic diseases 62 hyperphenylalaninemia HPA due 62 naloxol derivative 62 reduce serum phosphate 62 Ridaforolimus 62 Presents Preclinical Data 62 Humanized Anti 62 terfenadine 62 aspirin clopidogrel 62 Tyrosine Kinase Inhibitors 62 acetylcholinesterase AChE 62 inhalation powder 62 beta lactam 62 daptomycin 62 alkylating agents 62 cediranib 62 abacavir lamivudine 62 6 mercaptopurine 62 Tacrolimus 62 aurora kinase 62 lexidronam injection 62 Ceftaroline 62 AFREZZA TM 62 demonstrated antitumor activity 62 mild vasodilator 62 agonistic human 62 treat chronic sinusitis 62 delta gamma agonist 62 trastuzumab Herceptin ® 62 lipid lowering therapies 62 HCV Protease Inhibitor 62 Phase Ib Clinical Trial 62 Factor VIIa 62 Chronic lymphocytic leukemia CLL 62 Aurora kinase 62 HCV protease inhibitors 62 BUPHENYL R sodium phenylbutyrate 62 pegylated interferon alpha 2a 62 JAK2 inhibitor 62 Investigational eFlow Nebulizer System 62 follicular lymphoma FL 62 oxazolidinone 62 mTOR kinase 62 DuraSite ® 62 sorafenib Nexavar R 62 biologic therapeutics 62 systemic anaplastic large 62 SERMs 62 factor TNF receptor 62 oral renin inhibitor 62 VANTAS ® 62 Aztreonam 62 lucinactant 62 Refractory Hodgkin Lymphoma 62 Telatinib 62 Cardiotoxicity 62 metformin HCl 62 EGFR tyrosine kinase inhibitor 62 histone deacetylase HDAC inhibitors 62 EGFR tyrosine kinase inhibitors 62 anti tubercular 62 lymphoid malignancies 62 amprenavir 62 unresectable tumors 62 aflibercept VEGF Trap 62 alpha 2b 62 Altera Nebulizer System 62 vascular disrupting agent 62 Hodgkin lymphoma HL 62 Anthracyclines 62 metformin XR 62 rifamycin 62 oral levofloxacin 62 Clofarabine